Recombinant Human Complement factor B protein (His Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
His Tag
Activity
not tested
Cat no : Eg1224
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human Complement factor B protein Thr26-Leu764 (Accession# P00751-1) with a His tag at the C-terminus. |
GeneID | 629 |
Accession | P00751-1 |
PredictedSize | 84.1 kDa |
SDS-PAGE | 85-100 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Complement Factor B (CFB) is a vital component of the alternative pathway of the complement system, playing a central role in immune responses and inflammation. CFB is synthesized mainly by hepatocytes and macrophages and is involved in the defense against cellular damage and inflammation. It binds to C3b and is cleaved by Factor D to form the active Bb fragment, which then combines with C3b to generate the C3 or C5 convertase, initiating an inflammatory response, cytolysis, phagocytosis, and B cell activation. CFB is functionally similar to the classical pathway component C2, as both form the catalytic subunit of C3 convertases after activation and must be bound to be active.
References:
1. Wenjun Wang. et al. (2021). Dev Comp Immunol. 118:103992. 2. Eva Torreira. et al. (2009). J Immunol. 183(11):7347-7351. 3. Lin Zou. et al. (2016). J Immunol. 196(6):2788-2798.